Software and Technology leads with recent strong buy ratings for MSFT, ORCL, and CRM. Healthcare also sees significant analyst confidence with upgrades to MRK, VRTX, and ELV. Conversely, DDOG (Software) and DXCM (Medical Devices) received new or downgraded strong sell ratings, signaling caution in specific growth areas. Average target prices suggest continued upside in favored sectors.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.